ZYPREXA RELPREVV Drug Patent Profile
✉ Email this page to a colleague
When do Zyprexa Relprevv patents expire, and when can generic versions of Zyprexa Relprevv launch?
Zyprexa Relprevv is a drug marketed by Cheplapharm and is included in one NDA.
The generic ingredient in ZYPREXA RELPREVV is olanzapine pamoate. There are thirty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the olanzapine pamoate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZYPREXA RELPREVV?
- What are the global sales for ZYPREXA RELPREVV?
- What is Average Wholesale Price for ZYPREXA RELPREVV?
Summary for ZYPREXA RELPREVV
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 55 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZYPREXA RELPREVV |
DailyMed Link: | ZYPREXA RELPREVV at DailyMed |
![ZYPREXA RELPREVV drug patent expirations Drug patent expirations by year for ZYPREXA RELPREVV](/p/graph/s/t/ZYPREXA_RELPREVV-patent-expirations.png)
![Drug Prices for ZYPREXA RELPREVV](/p/graph/drug-price/ZYPREXA+RELPREVV.png)
US Patents and Regulatory Information for ZYPREXA RELPREVV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZYPREXA RELPREVV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZYPREXA RELPREVV
See the table below for patents covering ZYPREXA RELPREVV around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Indonesia | 25533 | ⤷ Sign Up | |
New Zealand | 503641 | Sustained release formulation of olanzapine pamoate suitable for treating psychotic patients | ⤷ Sign Up |
Turkey | 200000812 | ⤷ Sign Up | |
China | 1146422 | ⤷ Sign Up | |
Czech Republic | 20001162 | ⤷ Sign Up | |
Ireland | 911348 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZYPREXA RELPREVV
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0454436 | 9/1997 | Austria | ⤷ Sign Up | PRODUCT NAME: OLANZAPIN ODER EIN SAEUREADDITIONSSALZ HIEVON; REGISTRATION NO/DATE: EU/1/96/022/001 - EU/1/96/022/010 19960927 |
0454436 | C970015 | Netherlands | ⤷ Sign Up | PRODUCT NAME: OLANZAPINE, DESGEWENST IN DE VORM VAN EEN ZUURADDITIEZOUT; REGISTRATION NO/DATE: EU/1/96/022/001 - EU/1/96/022/010 19960927 |
0454436 | SPC/GB96/058 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: OLANZAPINE OPTIONALLY IN THE FORM OF AN ACID ADDITION SALT; REGISTERED: UK EU/1/96/022/001 19960927; UK EU/1/96/022/002 19960927; UK EU/1/96/022/003 19960927; UK EU/1/96/022/004 19960927; UK EU/1/96/022/005 19960927; UK EU/1/96/022/006 19960927; UK EU/1/96/022/007 19960927; UK EU/1/96/022/008 19960927; UK EU/1/96/022/009 19960927; UK EU/1/96/022/010 19960927 |
0454436 | CA 2001 00042 | Denmark | ⤷ Sign Up | |
0454436 | 97C0012 | Belgium | ⤷ Sign Up | PRODUCT NAME: OLANZAPINE; REGISTRATION NO/DATE: EU/1/96/022/001 19960927 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |